Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant of Lactococcus lactis coexpressing antigen and cytokine

Infection and Immunity

Volumn 66, Issue 7, 1998, Pages 3183-3189

  Steidler, Lothar ^a   Robinson, Karen ^b   Chamberlain, Lisa ^b   Schofield, Karin M ^b   Remaut, Erik ^a   Le Page, Richard W F ^b   Wells, Jeremy M ^b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DRUG VEHICLE; INTERLEUKIN 2; INTERLEUKIN 6; MITOMYCIN C;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DESIGN; IMMUNIZATION; LACTOCOCCUS LACTIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINE PRODUCTION;

LACTOCOCCUS LACTIS;

EID: 0031815046     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.7.3183-3189.1998     Document Type: Article

References (48)

1. Abraham, E., and S. Shah. 1992. Intranasal immunization with liposomes containing IL-2 enhances bacterial polysaccharide antigen-specific pulmonary secretory antibody response. J. Immunol. 149:3719-3726.
2. Borghesi, C., M. Regoli, E. Bertelli, and C. Nicoletti. 1996. Modifications of the follicle-associated epithelium by short-term exposure to a non-intestinal bacterium. J. Pathol. 180:326-332.
3. Carrier, M. J., S. N. Chatfield, G. Dougan, U. T. Nowicka, D. O'Callaghan, J. E. Beesley, S. Milano, E. Cillari, and F. Y. Liew. 1992. Expression of human IL-1 beta in Salmonella typhimurium. A model system for the delivery of recombinant therapeutic proteins in vivo. J. Immunol. 148:1176-1181.
4. Ceuppens, J. L., F. J. Bloemmen, and J. P. van Wauwe. 1985. T cell unresponsiveness to the mitogenic activity of OKT3 antibody results from a deficiency of monocyte Fc gamma receptors for murine IgG2a and inability to cross-link the T3-Ti complex. J. Immunol. 135:3882-3886.
5. Chamberlain, L., J. M. Wells, K. Robinson, K. Schofield, and R. W. F. Le Page. 1997. Mucosal immunization with recombinant Lactococcus lactis, p. 83-106. In G. Pozzi and J. M. Wells (ed.), Gram-positive bacteria as vaccine vehicles for mucosal immunization. Landes Bioscience, Austin, Tex.
6. Chiu, C.-P., C. Moulds, R. L. Coffman, D. Rennick, and F. Lee. 1988. Multiple biological activities are expressed by a mouse interleukin 6 cDNA clone isolated from bone marrow stromal cells. Proc. Natl. Acad. Sci. USA 86:7099-7103.
7. Denich, K., P. Borlin, P. D. O'Hanley, M. Howard, and A. W. Health. 1993. Expression of the murine interleukin-4 gene in an attenuated aroA strain of Salmonella typhimurium: persistence and immune response in BALB/c mice and susceptibility to macrophage killing. Infect. Immun. 61:4818-4827.
8. Devier, J., J. Content, C. Denys, P. Vandenbussche, L. Schandene, J. Wybran, and E. Dupont. 1989. High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokine production. Clin. Exp. Immunol. 77:221-225.
9. Dower, W. J., J. F. Miller, and C. W. Ragsdale. 1988. High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res. 16:6127-6145.
10. Duits, A. J., A. van Puijenbroek, H. Vermeulen, F. M. Hofhuis, J. G. van de Winkel, and P. J. Capel. 1993. Immunological activity of a liposomal IL-6 formulation. Vaccine 11:77-781.
11. Dunstan, S. J., A. J. Ramsay, and R. A. Strugnell. 1996. Studies of immunity and bacterial invasiveness in mice given a recombinant salmonella vector encoding murine interleukin-6. Infect. Immun. 64:2730-2736.
12. Eisel, U., W. Jarausch, K. Goretzki, A. Henschen, J. Engels, U. Weller, M. Hudel, E. Habermann, and H. Niemann. 1986. Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins. EMBO J. 5:2495-2502.
13. Gillis, S., M. M. Fern, W. Ou, and K. A. Smith. 1978. T cell growth factor: parameters of production and quantitative microassay for activity. J. Immunol. 120:2027-2032.
14. Grange, J. M., J. Gibson, T. W. Osborn, C. H. Collins, and M. D. Yates. 1983. What is BCG? Tubercle 64:129.
15. Gruzza, M., M. Fons, M. F. Ouriet, Y. Duval-Iflah, and R. Ducluzeau. 1994. Study of gene transfer in vitro and in the digestive tract of gnotobiotic mice from Lactococcus lactis strains to various strains belonging to human intestinal flora. Microb. Releases 2:183-189.
16. Heath, A. W., and J. H. Playfair. 1992. Cytokines as immunological adjuvants. Vaccine 10:427-434.
17. Kashima, N., C. Nishi-Takaoka, T. Fujita, S. Taki, G. Yamada, J. Hamuro, and T. Taniguchi. 1985. Unique structure of murine interleukin-2 as deduced from cloned cDNAs. Nature 313:402-404.
18. Klijn, N., A. H. Weerkamp, and W. M. de Vos. 1995. Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract. Appl. Environ. Microbiol. 61:2771-2774.
19. Kraehenbuhl, J.-P., and M. R. Neutra. 1992. Molecular and cellular basis of immune protection of mucosal surfaces. Physiol. Rev. 72:53-879.
20. Lachman, L. B., B. Ozpolat, and X. M. Rao. 1996. Cytokine-containing liposomes as vaccine adjuvants. Eur. Cytokine Netw. 7:693-698.
21. Leong, K. H., A. J. Ramsay, D. B. Boyle, and I. A. Ramshaw. 1994. Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus. J. Virol. 68:8125-8130.
22. Medaglini, D., G. Pozzi, T. P. King, and V. A. Fischetti. 1995. Mucosal and systemic responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonisation. Proc. Natl. Acad. Sci. USA 92:6868-6872.
23. Miller, S. I. 1991. PhoP/PhoQ: macrophage-specific modulators of Salmonella virulence. Mol. Microbiol. 5:2073-2078.
24. Murray, P. J., A. Aldovini, and R. A. Young. 1996. Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guerin strains that secrete cytokines. Proc. Natl. Acad. Sci. USA 93:934-939.
25. Norton, P. M., J. M. Wells, H. W. G. Brown, A. M. Macpherson, and R. W. F. Le Page. 1997. Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C. Vaccine 15:616-619.
26. Oka, Y., A. G. Rolink, S. Suematsu, T. Kishimoto, and F. Melchers. 1995. An interleukin-6 transgene expressed in B lymphocyte lineage cells overcomes the T cell-dependent establishment of normal levels of switched immunoglobulin isotypes. Eur. J. Immunol. 25:1332-1337.
27. Pockley, A. G., and P. C. Montgomery. 1991. In vivo adjuvant effect of interleukins 5 and 6 on rat tear IgA antibody responses. Immunology 73:19-23.
28. Poupart, P., P. Vandenabeele, S. Cayphas, J. Van Snick, G. Haegeman, V. Kruys, W. Fiers, and J. Content. 1987. B cell growth modulating and differentiating activity of recombinant human 26-kDa protein (BSF-2, HuIFN-beta 2, HPGF). EMBO J. 6:1219-1224.
29. Rafferty, D. E., and P. C. Montgomery. 1995. The effects of transforming growth factor-beta and interleukins 2, 5 and 6 on immunoglobulin production in cultured rat salivary gland tissues. Oral Microbiol. Immunol. 10:81-86.
30. Ramsay, A. J., A. J. Husband, I. A. Ramshaw, S. Bao, K. I. Matthaei, G. Koehler, and M. Kopf. 1994. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264:561-563.
31. Rautonen, J., N. Rautonen, N. L. Martin, R. Philip, and D. W. Wara. 1991. Serum interleukin-6 concentrations are elevated and associated with elevated tumour necrosis factor-alpha and immunoglobulin G and A concentrations in children with HIV infection. AIDS 5:1319-1325.
32. Robinson, K., L. M. Chamberlain, K. M. Schofield, J. M. Wells, and R. W. F. Le Page. 1997. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat. Biotechnol. 15:653-657.
33. Saito, S., M. Maruyama, Y. Kato, I. Moriyama, and M. Ichijo. 1991. Detection of IL-6 in human milk and its involvement in IgA production. J. Reprod. Immunol. 20:267-276.
34. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1990. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
35. Schijns, V. E., I. J. Claassen, A. A. Vermeulen, M. C. Horzinek, and A. D. Osterhaus. 1994. Modulation of antiviral immune responses by exogenous cytokincs: effects of tumour necrosis factor-alpha, interleukin-1 alpha, interleukin-2 and interferon gamma on the immunogenicity of an inactivated rabies vaccine. J. Gen. Virol. 75:55-63.
36. Steidler, J., W. Fiers, and E. Remaut. 1996. Expression of human and murine interleukins in Lactococcus lactis. NATO ASI Ser. H 98:63-79.
37. Steidler, L., J. M. Wells, A. Raeymaekers, J. Vandekerckhove, W. Fiers, and E. Remaut. 1995. Secretion of biologically active murine interleukin-2 by Lactococcus lactis subsp. lactis. Appl. Environ. Microbiol. 61:1627-1629.
38. Tacket, C. O., M. B. Sztein, G. A. Losonsky, S. S. Wasserman, J. P. Nataro, R. Edelman, D. Pickard, G. Dougan, S. N. Chatfield, and M. M. Levine. 1997. Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infect. Immun. 65:452-456.
39. Taga, T., Y. Kawanishi, R. R. Hardy, T. Hirano, and T. Kishimoto. 1987. Receptors for B cell stimulatory factor 2. Quantitative, specificity, distribution, and regulation of their expression. J. Exp. Med. 166:967-981.
40. Taylor, C. E. 1995. Cytokines as adjuvants for vaccines: antigen-specific responses differ from polyclonal responses. Infect. Immun. 63:3241-3244.
41. Theze, J., P. M. Alzari, and J. Bertoglio. 1996. Interleukin-2 and its receptors - recent advances and new immunological functions. Immunol. Today 17:481-486.
42. Van Asseldonk, M., G. Rutten, M. Oteman, R. J. Siezen, W. M. de Vos, and G. Simons. 1990. Cloning of usp45, a gene encoding a secreted protein from Lactococcus lactis subsp. lactis MG1363. Gene 95:155-160.
43. Van Snick, J. 1990. Interleukin-6: an overview. Annu. Rev. Immunol. 8:253-278.
44. Van Snick, J., S. Cayphas, A. Vink, P. G. Coulieand, and R. G. Simpson. 1986. Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc. Natl. Acad. Sci. USA 83:9679-9683.
45. Wells, J. M., K. Robinson, L. M. Chamberlain, K. M. Schofield, and R. W. F. Le Page. 1996. Lactic acid bacteria as vaccine delivery vehicles. Antonie Leeuwenhoek 70:317-330.
46. Wells, J. M., and K. M. Schofield. 1996. Cloning and expression vectors for lactococci. NATO ASI Ser. H 98:37-63.
47. Wells, J. M., P. W. Wilson, and R. W. F. Le Page. 1993. Improved cloning vectors and transformation procedure for Lactococcus lactis. J. Appl. Bacteriol. 74:629-636.
48. Wells, J. M., P. W. Wilson, P. M. Norton, M. J. Gasson, and R. W. F. Le Page. 1993. Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge. Mol. Microbiol. 8:1155-1162.